Table: Towa Pharmaceutical -2018/19 div forecast
Feb 12 (Reuters) -
Towa Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full year to Full year to
Mar 31, 2019 Mar 31, 2019
LATEST PREVIOUS
FORECAST FORECAST
Annual Div 107.50 yen 95.00 yen
-Q2 Div 47.50 yen 47.50 yen
-Q4 Div 60.00 yen 47.50 yen
NOTE - Towa Pharmaceutical Co Ltd.
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in 2006
allowed companies to pay and report dividends on a quarterly basis.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T
Recent news on TOWA PHARMACEUTICAL
See all newsTable: Towa Pharmaceutical -Q1 group results
Notice Of Acquisition Of Shares Of Tanabe Pharma Factory And Transfer Of Manufacturing And Marketing Approvals
Brief: Breckenridge Launches Tofacitinib Tablets, Generic Equivalent Of Xeljanz By Pfizer
Table: Towa Pharmaceutical -2025/26 parent results
Table: Towa Pharmaceutical -2025/26 group results